207 related articles for article (PubMed ID: 25959615)
1. Target-based biomarker selection - Mineralocorticoid receptor-related biomarkers and treatment outcome in major depression.
Büttner M; Jezova D; Greene B; Konrad C; Kircher T; Murck H
J Psychiatr Res; 2015; 66-67():24-37. PubMed ID: 25959615
[TBL] [Abstract][Full Text] [Related]
2. Markers of mineralocorticoid receptor function: changes over time and relationship to response in patients with major depression.
Murck H; Braunisch MC; Konrad C; Jezova D; Kircher T
Int Clin Psychopharmacol; 2019 Jan; 34(1):18-26. PubMed ID: 30300165
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid receptor-related markers and outcome of major depression: focus on blood pressure and electrolytes.
Murck H; Ploch M; Montgomery S
Int Clin Psychopharmacol; 2018 Jul; 33(4):224-228. PubMed ID: 29489494
[TBL] [Abstract][Full Text] [Related]
4. Genetic, molecular and clinical determinants for the involvement of aldosterone and its receptors in major depression.
Murck H; Büttner M; Kircher T; Konrad C
Nephron Physiol; 2014; 128(1-2):17-25. PubMed ID: 25376974
[TBL] [Abstract][Full Text] [Related]
5. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness.
DeRijk RH; Wüst S; Meijer OC; Zennaro MC; Federenko IS; Hellhammer DH; Giacchetti G; Vreugdenhil E; Zitman FG; de Kloet ER
J Clin Endocrinol Metab; 2006 Dec; 91(12):5083-9. PubMed ID: 17018659
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations.
Escoubet B; Couffignal C; Laisy JP; Mangin L; Chillon S; Laouénan C; Serfaty JM; Jeunemaitre X; Mentré F; Zennaro MC
Circ Cardiovasc Genet; 2013 Aug; 6(4):381-90. PubMed ID: 23852419
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
Kawarazaki W; Fujita T
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.
Otte C; Hinkelmann K; Moritz S; Yassouridis A; Jahn H; Wiedemann K; Kellner M
J Psychiatr Res; 2010 Apr; 44(6):339-46. PubMed ID: 19909979
[TBL] [Abstract][Full Text] [Related]
9. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
Jakobsen JC
Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
[TBL] [Abstract][Full Text] [Related]
10. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis.
Bienvenu LA; Morgan J; Rickard AJ; Tesch GH; Cranston GA; Fletcher EK; Delbridge LM; Young MJ
Endocrinology; 2012 Jul; 153(7):3416-25. PubMed ID: 22653557
[TBL] [Abstract][Full Text] [Related]
11. The Expression of RAC1 and Mineralocorticoid Pathway-Dependent Genes are Associated With Different Responses to Salt Intake.
Tapia-Castillo A; Carvajal CA; Campino C; Hill C; Allende F; Vecchiola A; Carrasco C; Bancalari R; Valdivia C; Lagos C; Martinez-Aguayo A; Garcia H; Aglony M; Baudrand RF; Kalergis AM; Michea LF; Riedel CA; Fardella CE
Am J Hypertens; 2015 Jun; 28(6):722-8. PubMed ID: 25430696
[TBL] [Abstract][Full Text] [Related]
12. Are we missing a mineralocorticoid in teleost fish? Effects of cortisol, deoxycorticosterone and aldosterone on osmoregulation, gill Na+,K+ -ATPase activity and isoform mRNA levels in Atlantic salmon.
McCormick SD; Regish A; O'Dea MF; Shrimpton JM
Gen Comp Endocrinol; 2008 May; 157(1):35-40. PubMed ID: 18462736
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the influence of ayurvedic formulation (Ayushman-15) on psychopathology, heart rate variability and stress hormonal level in major depression (Vishada).
Kishore RK; Abhishekh HA; Udupa K; Thirthalli J; Lavekar GS; Gangadhar BN; Raju TR; Sathyaprabha TN
Asian J Psychiatr; 2014 Dec; 12():100-7. PubMed ID: 25219946
[TBL] [Abstract][Full Text] [Related]
14. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
15. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.
Baker ME; Funder JW; Kattoula SR
J Steroid Biochem Mol Biol; 2013 Sep; 137():57-70. PubMed ID: 23907018
[TBL] [Abstract][Full Text] [Related]
16. [Influence of depressive history on biological parameters in major depression].
Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
[TBL] [Abstract][Full Text] [Related]
17. A viewpoint on aldosterone and BMI related brain morphology in relation to treatment outcome in patients with major depression.
Murck H; Lehr L; Jezova D
J Neuroendocrinol; 2023 Feb; 35(2):e13219. PubMed ID: 36539978
[TBL] [Abstract][Full Text] [Related]
18. Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from the early medication change trial in major depressive disorder.
Engelmann J; Murck H; Wagner S; Zillich L; Streit F; Herzog DP; Braus DF; Tadic A; Lieb K; Műller MB
World J Biol Psychiatry; 2022 Oct; 23(8):631-642. PubMed ID: 34985381
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone, mineralocorticoid receptor, and heart failure.
Messaoudi S; Azibani F; Delcayre C; Jaisser F
Mol Cell Endocrinol; 2012 Mar; 350(2):266-72. PubMed ID: 21784127
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of ligand specificity of the mineralocorticoid receptor.
Fuller PJ; Yao Y; Yang J; Young MJ
J Endocrinol; 2012 Apr; 213(1):15-24. PubMed ID: 22159507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
